Stellalife Vega Oral Care Peppermint Rinse
FDA Recall NDC 69685-143
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Stellalife Vega Oral Care Peppermint (NDC 69685-143). A significant event, classified as Class II, was initiated on Jun 05, 2024 by Stellalife, Inc.. The reported reason for this action was: "Microbial Contamination of Non-Sterile Products: presence of Terribacillus species organism"
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
Reported Recall Events
June 2024 Class II Recall: Microbial Contamination of Non-Sterile Products
Recall Number
Class II Terminated
Microbial Contamination of Non-Sterile Products: presence of Terribacillus species organism
Jun 05, 2024
Jul 24, 2024
31,110 x 16 fl. oz. bottle
Recall Profile & Regulatory Data
Event ID
94782
Classification
Class II
Enforcement Status
Terminated
Recalling Firm
Homeocare Laboratories, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide to 60 Physician offices
Termination Date
Nov 13, 2024
Product Description
STELLALIFE ADVANCED FORMULA Peppermint, VEGA Oral Care, Rinse, 16 fl oz (473 ml), Distributed by: StellaLife, 2875 NE 191 Street, Suite 500, Aventura, FL 33180, NDC 69685-143-16
Batch or Lot Expiration Information
Lot# 2550, exp. date 02-28-2026
Affected Packages Involved in this Recall
69685-143-16Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
